Logo image of LRN

STRIDE INC (LRN) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:LRN - US86333M1080 - Common Stock

66.21 USD
+0.26 (+0.39%)
Last: 12/26/2025, 8:04:00 PM
66.21 USD
0 (0%)
After Hours: 12/26/2025, 8:04:00 PM
Fundamental Rating

7

Overall LRN gets a fundamental rating of 7 out of 10. We evaluated LRN against 77 industry peers in the Diversified Consumer Services industry. LRN scores excellent points on both the profitability and health parts. This is a solid base for a good stock. A decent growth rate in combination with a cheap valuation! Better keep an eye on LRN. With these ratings, LRN could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year LRN was profitable.
In the past year LRN had a positive cash flow from operations.
In the past 5 years LRN has always been profitable.
In the past 5 years LRN always reported a positive cash flow from operatings.
LRN Yearly Net Income VS EBIT VS OCF VS FCFLRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of LRN (13.54%) is better than 88.31% of its industry peers.
The Return On Equity of LRN (20.68%) is better than 85.71% of its industry peers.
With an excellent Return On Invested Capital value of 16.01%, LRN belongs to the best of the industry, outperforming 93.51% of the companies in the same industry.
LRN had an Average Return On Invested Capital over the past 3 years of 11.97%. This is in line with the industry average of 10.17%.
The last Return On Invested Capital (16.01%) for LRN is above the 3 year average (11.97%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.54%
ROE 20.68%
ROIC 16.01%
ROA(3y)10.13%
ROA(5y)8.29%
ROE(3y)16.74%
ROE(5y)14.46%
ROIC(3y)11.97%
ROIC(5y)10.27%
LRN Yearly ROA, ROE, ROICLRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

With a decent Profit Margin value of 12.76%, LRN is doing good in the industry, outperforming 77.92% of the companies in the same industry.
In the last couple of years the Profit Margin of LRN has grown nicely.
LRN has a better Operating Margin (17.83%) than 79.22% of its industry peers.
In the last couple of years the Operating Margin of LRN has grown nicely.
LRN has a Gross Margin of 39.20%. This is comparable to the rest of the industry: LRN outperforms 44.16% of its industry peers.
In the last couple of years the Gross Margin of LRN has grown nicely.
Industry RankSector Rank
OM 17.83%
PM (TTM) 12.76%
GM 39.2%
OM growth 3Y23.39%
OM growth 5Y41.07%
PM growth 3Y23.52%
PM growth 5Y38.44%
GM growth 3Y3.53%
GM growth 5Y3.28%
LRN Yearly Profit, Operating, Gross MarginsLRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

8

2. Health

2.1 Basic Checks

LRN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, LRN has more shares outstanding
The number of shares outstanding for LRN has been increased compared to 5 years ago.
The debt/assets ratio for LRN has been reduced compared to a year ago.
LRN Yearly Shares OutstandingLRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
LRN Yearly Total Debt VS Total AssetsLRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

LRN has an Altman-Z score of 5.12. This indicates that LRN is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 5.12, LRN belongs to the best of the industry, outperforming 93.51% of the companies in the same industry.
LRN has a debt to FCF ratio of 1.74. This is a very positive value and a sign of high solvency as it would only need 1.74 years to pay back of all of its debts.
LRN has a Debt to FCF ratio of 1.74. This is in the better half of the industry: LRN outperforms 79.22% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that LRN is not too dependend on debt financing.
LRN has a Debt to Equity ratio (0.32) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 1.74
Altman-Z 5.12
ROIC/WACC2.07
WACC7.72%
LRN Yearly LT Debt VS Equity VS FCFLRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.3 Liquidity

LRN has a Current Ratio of 6.77. This indicates that LRN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 6.77, LRN belongs to the best of the industry, outperforming 97.40% of the companies in the same industry.
A Quick Ratio of 6.69 indicates that LRN has no problem at all paying its short term obligations.
LRN's Quick ratio of 6.69 is amongst the best of the industry. LRN outperforms 97.40% of its industry peers.
Industry RankSector Rank
Current Ratio 6.77
Quick Ratio 6.69
LRN Yearly Current Assets VS Current LiabilitesLRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

6

3. Growth

3.1 Past

LRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.82%, which is quite good.
Measured over the past years, LRN shows a very strong growth in Earnings Per Share. The EPS has been growing by 58.07% on average per year.
The Revenue has grown by 17.25% in the past year. This is quite good.
Measured over the past years, LRN shows a quite strong growth in Revenue. The Revenue has been growing by 18.24% on average per year.
EPS 1Y (TTM)17.82%
EPS 3Y33.5%
EPS 5Y58.07%
EPS Q2Q%48.94%
Revenue 1Y (TTM)17.25%
Revenue growth 3Y12.56%
Revenue growth 5Y18.24%
Sales Q2Q%12.67%

3.2 Future

The Earnings Per Share is expected to grow by 12.74% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.21% on average over the next years.
EPS Next Y26.61%
EPS Next 2Y14.79%
EPS Next 3Y12.74%
EPS Next 5YN/A
Revenue Next Year5.92%
Revenue Next 2Y5.3%
Revenue Next 3Y4.99%
Revenue Next 5Y4.21%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LRN Yearly Revenue VS EstimatesLRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
LRN Yearly EPS VS EstimatesLRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

9

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.22, the valuation of LRN can be described as reasonable.
Based on the Price/Earnings ratio, LRN is valued cheaper than 83.12% of the companies in the same industry.
When comparing the Price/Earnings ratio of LRN to the average of the S&P500 Index (26.57), we can say LRN is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.35, the valuation of LRN can be described as reasonable.
LRN's Price/Forward Earnings ratio is rather cheap when compared to the industry. LRN is cheaper than 92.21% of the companies in the same industry.
LRN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.04.
Industry RankSector Rank
PE 10.22
Fwd PE 8.35
LRN Price Earnings VS Forward Price EarningsLRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

88.31% of the companies in the same industry are more expensive than LRN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LRN indicates a rather cheap valuation: LRN is cheaper than 92.21% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.3
EV/EBITDA 4.55
LRN Per share dataLRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LRN has an outstanding profitability rating, which may justify a higher PE ratio.
LRN's earnings are expected to grow with 12.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)0.18
EPS Next 2Y14.79%
EPS Next 3Y12.74%

0

5. Dividend

5.1 Amount

No dividends for LRN!.
Industry RankSector Rank
Dividend Yield 0%

STRIDE INC

NYSE:LRN (12/26/2025, 8:04:00 PM)

After market: 66.21 0 (0%)

66.21

+0.26 (+0.39%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)10-28 2025-10-28/amc
Earnings (Next)01-26 2026-01-26/amc
Inst Owners110.97%
Inst Owner Change0.25%
Ins Owners3.04%
Ins Owner Change4.82%
Market Cap2.90B
Revenue(TTM)2.48B
Net Income(TTM)315.86M
Analysts81.82
Price Target128.82 (94.56%)
Short Float %12.26%
Short Ratio2.56
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.76%
Min EPS beat(2)-41.53%
Max EPS beat(2)26.01%
EPS beat(4)2
Avg EPS beat(4)-3.18%
Min EPS beat(4)-41.53%
Max EPS beat(4)26.01%
EPS beat(8)6
Avg EPS beat(8)44.6%
EPS beat(12)10
Avg EPS beat(12)44.76%
EPS beat(16)13
Avg EPS beat(16)18.17%
Revenue beat(2)2
Avg Revenue beat(2)1.75%
Min Revenue beat(2)0.16%
Max Revenue beat(2)3.34%
Revenue beat(4)4
Avg Revenue beat(4)2.14%
Min Revenue beat(4)0.16%
Max Revenue beat(4)3.34%
Revenue beat(8)7
Avg Revenue beat(8)2.35%
Revenue beat(12)11
Avg Revenue beat(12)2.73%
Revenue beat(16)15
Avg Revenue beat(16)2.74%
PT rev (1m)-4.41%
PT rev (3m)-24.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.95%
EPS NY rev (1m)-3.82%
EPS NY rev (3m)-9.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.91%
Revenue NY rev (1m)-1.21%
Revenue NY rev (3m)-5.82%
Valuation
Industry RankSector Rank
PE 10.22
Fwd PE 8.35
P/S 1.17
P/FCF 9.3
P/OCF 7.66
P/B 1.9
P/tB 2.57
EV/EBITDA 4.55
EPS(TTM)6.48
EY9.79%
EPS(NY)7.93
Fwd EY11.98%
FCF(TTM)7.12
FCFY10.75%
OCF(TTM)8.64
OCFY13.05%
SpS56.43
BVpS34.82
TBVpS25.73
PEG (NY)0.38
PEG (5Y)0.18
Graham Number71.26
Profitability
Industry RankSector Rank
ROA 13.54%
ROE 20.68%
ROCE 21.12%
ROIC 16.01%
ROICexc 24.34%
ROICexgc 34.29%
OM 17.83%
PM (TTM) 12.76%
GM 39.2%
FCFM 12.61%
ROA(3y)10.13%
ROA(5y)8.29%
ROE(3y)16.74%
ROE(5y)14.46%
ROIC(3y)11.97%
ROIC(5y)10.27%
ROICexc(3y)20.97%
ROICexc(5y)16.99%
ROICexgc(3y)36.26%
ROICexgc(5y)30.39%
ROCE(3y)15.79%
ROCE(5y)13.55%
ROICexgc growth 3Y30.19%
ROICexgc growth 5Y48.22%
ROICexc growth 3Y36.36%
ROICexc growth 5Y54.51%
OM growth 3Y23.39%
OM growth 5Y41.07%
PM growth 3Y23.52%
PM growth 5Y38.44%
GM growth 3Y3.53%
GM growth 5Y3.28%
F-Score7
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 1.74
Debt/EBITDA 0.87
Cap/Depr 57.81%
Cap/Sales 2.7%
Interest Coverage 44.78
Cash Conversion 68.05%
Profit Quality 98.82%
Current Ratio 6.77
Quick Ratio 6.69
Altman-Z 5.12
F-Score7
WACC7.72%
ROIC/WACC2.07
Cap/Depr(3y)56.69%
Cap/Depr(5y)59.43%
Cap/Sales(3y)3.07%
Cap/Sales(5y)3.32%
Profit Quality(3y)114.14%
Profit Quality(5y)117.4%
High Growth Momentum
Growth
EPS 1Y (TTM)17.82%
EPS 3Y33.5%
EPS 5Y58.07%
EPS Q2Q%48.94%
EPS Next Y26.61%
EPS Next 2Y14.79%
EPS Next 3Y12.74%
EPS Next 5YN/A
Revenue 1Y (TTM)17.25%
Revenue growth 3Y12.56%
Revenue growth 5Y18.24%
Sales Q2Q%12.67%
Revenue Next Year5.92%
Revenue Next 2Y5.3%
Revenue Next 3Y4.99%
Revenue Next 5Y4.21%
EBIT growth 1Y50.26%
EBIT growth 3Y38.88%
EBIT growth 5Y66.8%
EBIT Next Year35.87%
EBIT Next 3Y15.81%
EBIT Next 5Y18.08%
FCF growth 1Y115.04%
FCF growth 3Y38.85%
FCF growth 5Y60.14%
OCF growth 1Y79.65%
OCF growth 3Y27.9%
OCF growth 5Y40.03%

STRIDE INC / LRN FAQ

What is the ChartMill fundamental rating of STRIDE INC (LRN) stock?

ChartMill assigns a fundamental rating of 7 / 10 to LRN.


What is the valuation status for LRN stock?

ChartMill assigns a valuation rating of 9 / 10 to STRIDE INC (LRN). This can be considered as Undervalued.


Can you provide the profitability details for STRIDE INC?

STRIDE INC (LRN) has a profitability rating of 8 / 10.


What is the valuation of STRIDE INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for STRIDE INC (LRN) is 10.22 and the Price/Book (PB) ratio is 1.9.


What is the financial health of STRIDE INC (LRN) stock?

The financial health rating of STRIDE INC (LRN) is 8 / 10.